
Rohit Jain
About Rohit Jain
Data last updated:
Rohit Jain is a Director at Titan Biotech Limited (since 2021), Director at Peptech Biosciences Limited (since 2021) and Director at Idcsprotech Solutions Private Limited (since 2023), and holds 9 more current directorships. The companies operate in Life Sciences, Agriculture and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹228 Cr; the largest is Titan Biotech Limited at ₹160 Cr (FY 2025). Earlier, Rohit Jain was a Director at E2fa Foundation (2024) and Director at Regent India Solutions Private Limited (2023) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2021 | 1992 | ₹160 Cr (FY 2025) | Active | |
| Director | 02 Aug 2021 | 2011 | ₹67.59 Cr (FY 2025) | Active | |
| Director | 05 Oct 2023 | 2023 | ₹34.4 Lakh (FY 2025) | Active | |
| Designated Partner | 11 Mar 2025 | 2025 | Active | ||
| Additional Director | 01 Jul 2024 | 2023 | Active | ||
| Designated Partner | 08 Dec 2023 | 2023 | Active | ||
| Director | 04 Oct 2023 | 2023 | Active | ||
| Director | 04 Oct 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jan 2024 | 2024 | ₹8,000 (FY 2025) | Active | |
| Director | 09 Mar 2023 | 2023 | Active | ||
| Director | 14 Jan 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rohit Jain
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Jain
Rohit Jain currently holds 12 directorships: Titan Biotech Limited (Director, since 26 Jul 2021, revenue ₹160 Cr (FY 2025)); Peptech Biosciences Limited (Director, since 02 Aug 2021, revenue ₹67.59 Cr (FY 2025)); Idcsprotech Solutions Private Limited (Director, since 05 Oct 2023, revenue ₹34.4 Lakh (FY 2025)); Kestavaa Global Strategies Llp (Designated Partner, since 11 Mar 2025); Concare Healthtech Private Limited (Additional Director, since 01 Jul 2024); and 7 more.
Rohit Jain was first appointed on 14 Jan 2020 as Director at Chimera Q Private Limited. The most recent appointment on record is 11 Mar 2025 at Kestavaa Global Strategies Llp.
The 3 current companies of Rohit Jain that report revenue have a combined latest revenue of ₹228 Cr: Titan Biotech Limited ₹160 Cr (FY 2025); Peptech Biosciences Limited ₹67.59 Cr (FY 2025); Idcsprotech Solutions Private Limited ₹34.4 Lakh (FY 2025).
Rohit Jain held 3 earlier board appointments: E2fa Foundation (Director, 07 Jan 2024 to 25 Oct 2024); Regent India Solutions Private Limited (Director, 09 Mar 2023 to 09 Oct 2023); Chimera Q Private Limited (Director, from 14 Jan 2020).
The current boards of Rohit Jain's companies include Abhishek Agarwal (Titan Biotech Limited), Brijesh Kumar Singh (Titan Biotech Limited), Charanjit Singh (Titan Biotech Limited), Debendra Kumar Sabat (Titan Biotech Limited), Dhairya Madan (Titan Biotech Limited), Manju Singla (Titan Biotech Limited), among others.